9 Meters Biopharma Common Stock

9 Meters Biopharma (NMTR) currently reports a common stock of $1.4K as of March 2023. That compares with $26K in the prior-year period — down 94.4% year over year. Use the charts on this page to explore 9 Meters Biopharma's common stock history and peer comparisons.

9 Meters Biopharma's common stock decreased from $26K to $1.4K — a 94.4% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

9 Meters Biopharma reported $1.4K in common stock as of March 2023. That compares with $26K in the prior-year period — down 94.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $1.4K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for 9 Meters Biopharma, and consider following NMTR for alerts when major investors trade the stock.

9 Meters Biopharma is classified in the Technology sector. On common stock, it currently shows $1.4K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing NMTR with unrelated industries.